Effective Medication Options For Alcohol Withdrawal Treatment

what type of medication is given for alcohol withdrawal

Alcohol withdrawal syndrome is a cluster of symptoms that occur when a person stops drinking alcohol, especially after prolonged and heavy use. Symptoms can range from mild to severe, with the most severe being life-threatening. Treatment for alcohol withdrawal typically involves medication and therapy, with the goal of managing symptoms and preventing complications. The choice of medication depends on various factors, including the severity of withdrawal, the presence of co-existing health conditions, and the patient's medical history. This article will explore the different types of medications used in alcohol withdrawal treatment and how they help manage symptoms and reduce the risk of complications.

Characteristics Values
First-choice medications Benzodiazepines (Benzos)
Benzodiazepines safety Generally effective and safe for short periods of time
Benzodiazepines administration Fixed-schedule, Symptom-triggered, Loading dose regimen
Benzodiazepines examples Lorazepam, Diazepam
Other medications Carbamazepine, Haloperidol, Beta blockers, Clonidine, Phenytoin, Chlordiazepoxide, Acamprosate, Disulfiram
Other treatments Intravenous fluids, Antinausea medicines, Group psychotherapy, Counselling, Cognitive behavioural therapy (CBT)
Side effects Drowsiness

cyalcohol

Benzodiazepines are the first-choice medication

Benzodiazepines are effective in treating alcohol withdrawal syndrome as they are cross-tolerant with alcohol. They can be administered orally or intravenously/intramuscularly, depending on the patient's needs and the severity of their symptoms. For patients with severe liver dysfunction or those at high risk of experiencing serious medical consequences following sedation, short-acting benzodiazepines like lorazepam are recommended.

Fixed-schedule regimens involve administering fixed doses of benzodiazepines at specific intervals, with additional doses given as needed based on the severity of withdrawal symptoms. Symptom-triggered regimens, on the other hand, involve administering medication only when the CIWA-Ar score is higher than 8 points. This approach can reduce the total amount of medication used and shorten treatment duration.

Benzodiazepines are generally safe and well-tolerated, but it's important to note that they can cause drowsiness. Therefore, individuals taking this medication should refrain from driving or operating heavy machinery. Additionally, benzodiazepines should not be taken with opiate-based medicines or illegal opiate drugs as this can be dangerous.

When treating alcohol withdrawal, it is common to combine benzodiazepines with other medications or treatments for related health issues. For example, IV fluids may be administered for dehydration, and antinausea medicines may be given if vomiting occurs.

cyalcohol

Lorazepam for severe liver dysfunction

Alcohol withdrawal can cause a range of symptoms, from mild to severe and sometimes life-threatening. Severe alcohol withdrawal may present with hallucinations, seizures, or delirium tremens. The first-choice medication to treat alcohol withdrawal symptoms is benzodiazepines ("benzos"), which are generally safe and effective. They are typically administered in gradually decreasing doses to prevent the recurrence of withdrawal symptoms.

Lorazepam is a short-acting benzodiazepine that is used in patients with severe liver dysfunction and those at high risk of experiencing serious medical consequences following sedation, such as those with severe lung disease or the elderly. It is considered the benzodiazepine best tolerated by patients with advanced liver disease. This is because, unlike other benzodiazepines, it is metabolized by the liver into inactive metabolites. While clinically apparent liver injury from lorazepam has been reported, it is extremely rare, with only a single case reported in the literature despite its widespread use for several decades. The patient in this case made a prompt and complete recovery upon stopping the medication, with no evidence of residual or chronic injury.

Lorazepam is also used in the therapy of status epilepticus and for preoperative sedation, as well as in the management of nausea and vomiting. It is widely used orally in the treatment of anxiety. The most common side effects of lorazepam are dose-related and include drowsiness, lethargy, ataxia, dysarthria, and dizziness. Tolerance develops to these side effects, but there is also a risk of dependence and severe, potentially life-threatening withdrawal symptoms if the medication is discontinued suddenly. Therefore, caution should be exercised when using lorazepam, especially in patients with a history of substance use disorders.

In the context of alcohol withdrawal, lorazepam is particularly indicated in patients with a history of seizures during alcohol withdrawal syndrome (AWS). These patients may require high doses of lorazepam to prevent further seizures and the development of delirium tremens. They should be admitted and monitored for at least 36-48 hours to watch for further seizures or delirium tremens, and a detailed neurological and medical examination, blood investigations, and brain imaging are necessary to rule out alternative causes.

cyalcohol

Diazepam for seizures

Alcohol withdrawal can cause a range of symptoms, from mild to severe, and in some cases, it can even be life-threatening. Severe alcohol withdrawal may present with hallucinations, seizures, or delirium tremens. Seizures during alcohol withdrawal indicate severe alcohol withdrawal.

Benzodiazepines are the first-choice medications for treating alcohol withdrawal symptoms. They are effective and usually safe, especially when used for short periods of time. Diazepam (Valium) is a long-acting benzodiazepine that has been shown to be excellent in treating alcohol withdrawal symptoms, including seizures. It has the shortest time to peak effect among benzodiazepines, facilitating rapid control of symptoms and accurate titration to avoid over-sedation. The long elimination half-life of diazepam and its active metabolite, desmethyldiazepam, results in a gradual decrease in their levels, leading to a smoother withdrawal process with a lower risk of breakthrough symptoms and rebound phenomena. This may also contribute to a decreased risk of seizures.

Diazepam can be administered orally, with doses as high as 2,000 mg per day having been used in the treatment of alcohol withdrawal. However, due to concerns about exceptionally high dosages, undertreatment of alcohol withdrawal is a common issue. A loading dose regimen for alcohol withdrawal involves administering 20 mg of diazepam orally every 2 hours, which has been found to be effective. Alternatively, intravenous or intramuscular injections of 2 mg lorazepam are recommended for patients with seizures during the current withdrawal period or a history of withdrawal seizures. While lorazepam is considered more effective in preventing seizure recurrence due to its consistent plasma level distribution, diazepam may be preferred for its simplicity of administration.

In patients with severe liver dysfunction or a high risk of serious medical consequences following sedation, short-acting benzodiazepines like lorazepam are recommended. However, diazepam has been found to be safe for patients with liver disease and elderly patients when administered based on symptoms. Diazepam should only be avoided when intramuscular administration is the only option, as its lipophilicity can result in slow absorption in such cases.

cyalcohol

Acamprosate to prevent relapse

Alcohol withdrawal can cause a range of symptoms, from mild to severe and sometimes life-threatening. The symptoms occur when a person with alcohol use disorder (AUD) stops or significantly reduces their alcohol intake. The most common treatment for alcohol withdrawal is benzodiazepines ("benzos"), which are effective and safe, especially when used for short periods of time. However, other medications can be used in conjunction with benzos, such as acamprosate, to aid in relapse prevention.

Acamprosate, also known as Campral or calcium bisacetylhomotaurinate, is a medication that has been shown to be effective in treating alcohol-dependent patients and maintaining abstinence. It is clinically used in many countries for relapse prevention and has been proven safe and well-tolerated. Acamprosate does not affect craving but helps to significantly reduce the risk of drinking again.

In a placebo-controlled study, patients receiving acamprosate showed a higher continuous abstinence rate within the first 60 days of treatment compared to those on placebo (67% vs 50%). The acamprosate group also had a longer mean abstinence duration of 224 days compared to 163 days for the placebo group. Additionally, at the end of a further 48 weeks without medication, 39% of the acamprosate group remained abstinent, compared to only 17% of the placebo group.

The exact mechanism of action of acamprosate is still not fully understood. While there is evidence suggesting that it interferes with the glutamate system, it has been shown that acamprosate does not interact with proposed glutamate receptor mechanisms, such as NMDA receptors or metabotropic glutamate receptor group I.

Overall, acamprosate is a valuable medication for preventing relapse in alcohol-dependent patients, aiding in their journey towards long-term abstinence and recovery. It is essential to consult a healthcare professional for personalized advice and to determine the most suitable treatment plan for alcohol withdrawal.

cyalcohol

Disulfiram as a deterrent

Alcohol withdrawal can cause a range of symptoms, from mild to severe, and in some cases, it can even be life-threatening. While benzodiazepines are the first-choice medication for treating alcohol withdrawal, disulfiram, formerly known by the brand name Antabuse, is another medication approved by the FDA for treating alcohol use disorders (AUD).

Disulfiram is designed as a deterrent to drinking. It works by interfering with the body's ability to break down alcohol, blocking the enzyme aldehyde dehydrogenase, which is responsible for converting acetaldehyde into acetic acid. This blockage results in a rapid rise of acetaldehyde in the blood when alcohol is consumed, leading to the disulfiram-alcohol reaction. This reaction causes a range of unpleasant symptoms, including diaphoresis, palpitations, facial flushing, nausea, vertigo, hypotension, and tachycardia. The reaction typically occurs within 10 to 30 minutes of drinking and generally lasts between 30 to 60 minutes. The intensity of the reaction varies with the amount of disulfiram and alcohol ingested, and it can be life-threatening in rare cases.

The goal of disulfiram therapy is to discourage alcohol intake by producing these unpleasant side effects when alcohol is consumed. It is most effective for patients who have already stopped drinking or are in the early stages of abstinence, are highly motivated to maintain sobriety, and receive adequate supervision and support from friends, family, or a treatment program. Disulfiram is typically prescribed as a 250 mg daily dose, but doses can range from 125 mg to 500 mg. It is taken orally in tablet form or crushed and mixed with non-alcoholic beverages. Treatment can continue for months or even years until the individual feels they have achieved permanent self-control.

While disulfiram can be a valuable part of a comprehensive treatment approach for some individuals, it has received mixed reviews regarding its effectiveness. Some experts question its efficacy due to the unpredictable intensity and timing of the disulfiram-alcohol reaction. Additionally, disulfiram does not directly address alcohol cravings or withdrawal symptoms. It is important to note that disulfiram should not be used in individuals with liver disease and should be used with caution in those with heart disease.

Frequently asked questions

Benzodiazepines (benzos) are the first-choice medication for treating alcohol withdrawal. They are usually effective and safe when used for short periods. Other medications can be used in addition to benzos, such as carbamazepine, haloperidol, beta blockers, clonidine, and phenytoin.

Examples of benzodiazepines include diazepam and lorazepam.

Benzodiazepines can be administered via a fixed-schedule or symptom-triggered regimen. In fixed-schedule regimens, benzodiazepines are administered at specific intervals, with additional doses given based on symptom severity. Symptom-triggered regimens involve administering medication based on the withdrawal severity as assessed by withdrawal rating scales.

Acamprosate (brand name Campral) is used to prevent relapse in those who have achieved abstinence. It works by reducing alcohol cravings. Disulfiram (brand name Antabuse) is another option for those trying to achieve abstinence but are concerned about relapsing. It acts by causing unpleasant physical reactions if alcohol is consumed.

Written by
Reviewed by

Explore related products

Share this post
Print
Did this article help you?

Leave a comment